The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune‐associated epilepsy: Conceptual definitions
Open accessAbstract
Seizures are a well‐recognized and often prominent manifestation of autoimmune encephalitic syndromes. Progress in detection of pathogenic neural autoantibodies has led to increased awareness of autoimmune causes of seizures. Clinical studies of patients with these autoantibodies have improved our understanding of the seizure characteristics, treatments, and seizure prognosis in these disorders. The International League Against Epilepsy (ILAE) Autoimmunity and Inflammation Taskforce proposes conceptual definitions for two main diagnostic entities: (a) acute symptomatic seizures secondary to autoimmune encephalitis, and (b) autoimmune‐associated epilepsy, the latter of which suggests an enduring predisposition to seizures. Such a distinction is relevant when discussing the pathophysiology, treatment, prognosis, and social consequences of these disorders. We discuss the role of biomarkers in the application of these conceptual definitions and illustrate their use in patients cared for by members of the task force.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ILAE official report: a practical clinical definition of epilepsy
Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., Engel, J., Forsgren, L., French, J. A., Glynn, M., et al. (2014) · Epilepsia · doi:10.1111/epi.12550 · Cited by 6,108
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Self-citationFisher, R. S., Boas, W. V. E., Blume, W., Elger, C., Genton, P., Lee, P., & Engel, J. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.66104.x · Cited by 3,671
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
Beghi, E., Berg, A., Carpio, A., Forsgren, L., Hesdorffer, D. C., Hauser, W. A., Malmgren, K., Shinnar, S., Temkin, N., Thurman, D., et al. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00273_1.x · Cited by 2,296
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis
Irani, S. R., Michell, A. W., Lang, B., Pettingill, P., Waters, P., Johnson, M. R., Schott, J. M., Armstrong, R. J. E., S. Zagami, A., Bleasel, A., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22307 · Cited by 928
Self-citationRecommendation for a definition of acute symptomatic seizure
Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02285.x · Cited by 924
Clinical analysis of anti-Ma2-associated encephalitis
Dalmau, J. (2004) · Brain · doi:10.1093/brain/awh203 · Cited by 771
Extreme delta brush: A unique EEG pattern in adults with anti-NMDA receptor encephalitis
Schmitt, S. E., Pargeon, K., Frechette, E. S., Hirsch, L. J., Dalmau, J., & Friedman, D. (2012) · Neurology · doi:10.1212/wnl.0b013e3182698cd8 · Cited by 716
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis
Bien, C. G., Vincent, A., Barnett, M. H., Becker, A. J., Blumcke, I., Graus, F., Jellinger, K. A., Reuss, D. E., Ribalta, T., Schlegel, J., et al. (2012) · Brain · doi:10.1093/brain/aws082 · Cited by 695
Self-citationAnti-LGI1 encephalitis: Clinical syndrome and long-term follow-up
van Sonderen, A., Thijs, R. D., Coenders, E. C., Jiskoot, L. C., Sanchez, E., de Bruijn, M. A. A. M., van Coevorden-Hameete, M. H., Wirtz, P. W., Schreurs, M. W. J., Sillevis Smitt, P. A. E., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003173 · Cited by 658
Armangue, T., Spatola, M., Vlagea, A., Mattozzi, S., Cárceles-Cordon, M., Martinez-Heras, E., Llufriu, S., Muchart, J., Erro, M. E., Abraira, L., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30244-8 · Cited by 658
Dalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
Petit-Pedrol, M., Armangue, T., Peng, X., Bataller, L., Cellucci, T., Davis, R., McCracken, L., Martinez-Hernandez, E., Mason, W. P., Kruer, M. C., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70299-0 · Cited by 616
Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis
Malter, M. P., Helmstaedter, C., Urbach, H., Vincent, A., & Bien, C. G. (2010) · Annals of Neurology · doi:10.1002/ana.21917 · Cited by 514
Self-citationScheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2019) · Journal of the Japan Epilepsy Society · doi:10.3805/jjes.37.6 · Cited by 512
New-onset refractory status epilepticus: Etiology, clinical features, and outcome
Gaspard, N., Foreman, B. P., Alvarez, V., Cabrera Kang, C., Probasco, J. C., Jongeling, A. C., Meyers, E., Espinera, A., Haas, K. F., Schmitt, S. E., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001940 · Cited by 488
Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances
Varadkar, S., Bien, C. G., Kruse, C. A., Jensen, F. E., Bauer, J., Pardo, C. A., Vincent, A., Mathern, G. W., & Cross, J. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70260-6 · Cited by 479
Self-citationEncephalitis and GABA B receptor antibodies: Novel findings in a new case series of 20 patients
Höftberger, R., Titulaer, M. J., Sabater, L., Dome, B., Rózsás, A., Hegedus, B., Hoda, M. A., Laszlo, V., Ankersmit, H. J., Harms, L., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a9585f · Cited by 475
The clinical spectrum of Caspr2 antibody–associated disease
van Sonderen, A., Ariño, H., Petit-Pedrol, M., Leypoldt, F., Körtvélyessy, P., Wandinger, K.-P., Lancaster, E., Wirtz, P. W., Schreurs, M. W. J., Sillevis Smitt, P. A. E., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002917 · Cited by 441
Destruction of neurons by cytotoxic T cells: A new pathogenic mechanism in rasmussen's encephalitis
Bien, C. G., Bauer, J., Deckwerth, T. L., Wiendl, H., Deckert, M., Wiestler, O. D., Schramm, J., Elger, C. E., & Lassmann, H. (2002) · Annals of Neurology · doi:10.1002/ana.10100 · Cited by 364
Self-citationExpanded phenotypes and outcomes among 256 LGI 1/ CASPR 2‐ I g G –positive patients
Gadoth, A., Pittock, S. J., Dubey, D., McKeon, A. B., Britton, J. W., Schmeling, J. E., Smith, A., Kotsenas, A. L., Watson, R. E., Lachance, D. H., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24979 · Cited by 361
Self-citationAutoimmune Epilepsy: Clinical Characteristics and Response to Immunotherapy
Quek, A. M. L. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2985 · Cited by 359
Pitkänen, A., Lukasiuk, K., Dudek, F. E., & Staley, K. J. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022822 · Cited by 357
Anti-LGI1–associated cognitive impairment: Presentation and long-term outcome
Ariño, H., Armangué, T., Petit-Pedrol, M., Sabater, L., Martinez-Hernandez, E., Hara, M., Lancaster, E., Saiz, A., Dalmau, J., & Graus, F. (2016) · Neurology · doi:10.1212/wnl.0000000000003009 · Cited by 348
Investigations in GABA A receptor antibody-associated encephalitis
Spatola, M., Petit-Pedrol, M., Simabukuro, M. M., Armangue, T., Castro, F. J., Barcelo Artigues, M. I., Julià Benique, M. R., Benson, L., Gorman, M., Felipe, A., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003713 · Cited by 337
Finke, C., Prüss, H., Heine, J., Reuter, S., Kopp, U. A., Wegner, F., Then Bergh, F., Koch, S., Jansen, O., Münte, T., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4226 · Cited by 318
Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis
Kelley, B. P., Patel, S. C., Marin, H. L., Corrigan, J. J., Mitsias, P. D., & Griffith, B. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5086 · Cited by 310
Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy
Peltola, J., Kulmala, P., Isojärvi, J., Saiz, A., Latvala, K., Palmio, J., Savola, K., Knip, M., Keränen, T., & Graus, F. (2000) · Neurology · doi:10.1212/wnl.55.1.46 · Cited by 296
Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA B R encephalitis
de Bruijn, M. A. A. M., van Sonderen, A., van Coevorden-Hameete, M. H., Bastiaansen, A. E. M., Schreurs, M. W. J., Rouhl, R. P. W., van Donselaar, C. A., Majoie, M. H. J. M., Neuteboom, R. F., Sillevis Smitt, P. A. E., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007475 · Cited by 266
Analysis of relapses in anti-NMDAR encephalitis
Gabilondo, I., Saiz, A., Galán, L., González, V., Jadraque, R., Sabater, L., Sans, A., Sempere, A., Vela, A., Villalobos, F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31822cfc6b · Cited by 264
Al-Diwani, A., Handel, A., Townsend, L., Pollak, T., Leite, M. I., Harrison, P. J., Lennox, B. R., Okai, D., Manohar, S. G., & Irani, S. R. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30001-x · Cited by 241
Self-citationAutoimmune seizures and epilepsy
Geis, C., Planagumà, J., Carreño, M., Graus, F., & Dalmau, J. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125178 · Cited by 232
Population-Level Evidence for an Autoimmune Etiology of Epilepsy
Ong, M.-S., Kohane, I. S., Cai, T., Gorman, M. P., & Mandl, K. D. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.188 · Cited by 229
Pardo, C. A., Vining, E. P. G., Guo, L., Skolasky, R. L., Carson, B. S., & Freeman, J. M. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.33103.x · Cited by 221
Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis
Navarro, V., Kas, A., Apartis, E., Chami, L., Rogemond, V., Levy, P., Psimaras, D., Habert, M.-O., Baulac, M., Delattre, J.-Y., et al. (2016) · Brain · doi:10.1093/brain/aww012 · Cited by 204
Diagnosis and staging of Rasmussen’s encephalitis by serial MRI and histopathology
Bien, C. G., Urbach, H., Deckert, M., Schramm, J., Wiestler, O. D., Lassmann, H., & Elger, C. E. (2002) · Neurology · doi:10.1212/wnl.58.2.250 · Cited by 202
Self-citationCerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis—A Systematic Analysis
Blinder, T., & Lewerenz, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00804 · Cited by 195
Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis
Spatola, M., & Dalmau, J. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000449 · Cited by 173
Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis
Bernal, F., Graus, F., Pifarré, À., Saiz, A., Benyahia, B., & Ribalta, T. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0498-0 · Cited by 171
Predictive models in the diagnosis and treatment of autoimmune epilepsy
Dubey, D., Singh, J., Britton, J. W., Pittock, S. J., Flanagan, E. P., Lennon, V. A., Tillema, J., Wirrell, E., Shin, C., So, E., et al. (2017) · Epilepsia · doi:10.1111/epi.13797 · Cited by 166
Self-citationGAD Antibodies in NIDDM: Ten-year follow-up from the diagnosis
Niskanen, L. K., Tuomi, T., Karjalainen, J., Groop, L. C., & Uusitupa, M. I. J. (1995) · Diabetes Care · doi:10.2337/diacare.18.12.1557 · Cited by 164
Walikonis, J., & Lennon, V. A. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.12.1161 · Cited by 159
Tonic seizures: A diagnostic clue of anti-LGI1 encephalitis?
Andrade, D. M., Tai, P. C., Dalmau, J. O., & Wennberg, R. A. (2011) · Neurology · doi:10.1212/wnl.0b013e3182152808 · Cited by 149
Limbic encephalitis due to GABABand AMPA receptor antibodies: a case series
Onugoren, M. D., Deuretzbacher, D., Haensch, C., Hagedorn, H.-J., Halve, S., Isenmann, S., Kramme, C., Lohner, H., Melzer, N., Monotti, R., et al. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308814 · Cited by 136
Self-citationSeizure outcomes in patients with anti‐ NMDAR encephalitis: A follow‐up study
Liu, X., Yan, B., Wang, R., Li, C., Chen, C., Zhou, D., & Hong, Z. (2017) · Epilepsia · doi:10.1111/epi.13929 · Cited by 128
Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis
Miller, T. D., Chong, T. T. ‐., Davies, A. M. A., Ng, T. W. C., Johnson, M. R., Irani, S. R., Vincent, A. C., Husain, M., Jacob, S., Maddison, P., et al. (2017) · Brain · doi:10.1093/brain/awx070 · Cited by 127
Self-citationEEG findings in NMDA encephalitis – A systematic review
Gillinder, L., Warren, N., Härtel, G., Dionisio, S. A., & O’Gorman, C. (2018) · Seizure · doi:10.1016/j.seizure.2018.12.015 · Cited by 125
Kotsenas, A. L., Watson, R. E., Pittock, S. J., Britton, J. W., Hoye, S. L., Quek, A. M. L., Shin, C., & Klein, C. J. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3633 · Cited by 120
Self-citationAntibody-associated CNS syndromes without signs of inflammation in the elderly
Escudero, D., Guasp, M., Ariño, H., Gaig, C., Martínez‐Hernández, E., Dalmau, J. O., & Graus, F. (2017) · Neurology · doi:10.1212/wnl.0000000000004541 · Cited by 119
The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies
van Coevorden‐Hameete, M. H., de Bruijn, M. A. A. M., de Graaff, E., Bastiaansen, A. E. M., Schreurs, M. W. J., Demmers, J., Ramberger, M., Hulsenboom, E., Nagtzaam, M. M. P., Boukhrissi, S., et al. (2019) · Brain · doi:10.1093/brain/awz094 · Cited by 119
Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies
Malter, M. P., Frisch, C. M., Zeitler, H.-J., Surges, R., Urbach, H., Helmstaedter, C., Elger, C. E., & Bien, C. G. (2015) · Seizure · doi:10.1016/j.seizure.2015.05.017 · Cited by 101
Self-citationAutoimmune epilepsy in children: Case series and proposed guidelines for identification
Suleiman, J., Brilot, F., Lang, B., Vincent, A. C., & Dale, R. C. (2013) · Epilepsia · doi:10.1111/epi.12142 · Cited by 98
Self-citationSeizure specificities in patients with antibody‐mediated autoimmune encephalitis
Vogrig, A., Joubert, B., André‐Obadia, N., Gigli, G. L., Rheims, S., & Honnorat, J. (2019) · Epilepsia · doi:10.1111/epi.16282 · Cited by 77
Autoimmunity, seizures, and status epilepticus
Davis, R. A., & Dalmau, J. O. (2013) · Epilepsia · doi:10.1111/epi.12276 · Cited by 74
Britton, J. W. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63432-0.00013-x · Cited by 74
Self-citationElectroclinical features of seizures associated with autoimmune encephalitis
Steriade, C., Moosa, A. N. V., Hantus, S. T., Prayson, R. A., Alexopoulos, A. V., & Rae-Grant, A. D. (2018) · Seizure · doi:10.1016/j.seizure.2018.06.021 · Cited by 73
Self-citationRamanathan, S., O’Grady, G. L., Malone, S., Spooner, C. G., Brown, D. A., Gill, D. S., Brilot, F., & Dale, R. C. (2018) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14032 · Cited by 71
Self-citationToledano, M., & Pittock, S. J. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1552625 · Cited by 65
Lilleker, J. B., Biswas, V., & Mohanraj, R. (2014) · Seizure · doi:10.1016/j.seizure.2014.04.009 · Cited by 60
Frontal infraslow activity marks the motor spasms of anti-LGI1 encephalitis
Wennberg, R. A., Steriade, C., Chen, R. E., & Andrade, D. M. (2017) · Clinical Neurophysiology · doi:10.1016/j.clinph.2017.10.014 · Cited by 38
Self-citationGillinder, L., Tjoa, L., Mantzioris, B. X., Blum, S., & Dionisio, S. A. (2017) · Epileptic Disorders · doi:10.1684/epd.2017.0946 · Cited by 29
Atmaca, M. M., Tüzün, E., Erdağ, E., Bebek, N., Baykan, B. B., & Gürses, C. (2017) · Acta Neurologica Belgica · doi:10.1007/s13760-017-0796-5 · Cited by 18
Recognizing autoimmune encephalitis as a cause of seizures
Britton, J. W., & Dalmau, J. O. (2019) · Neurology · doi:10.1212/wnl.0000000000007444 · Cited by 10
Self-citation
Cited by
Wirrell, E. C., Nabbout, R., Scheffer, I. E., Alsaadi, T., Bogacz, A., French, J. A., Hirsch, E., Jain, S., Kaneko, S., Riney, K., et al. (2022) · Epilepsia · doi:10.1111/epi.17237 · Cited by 296
Riney, K., Bogacz, A., Somerville, E., Hirsch, E., Nabbout, R., Scheffer, I. E., Zuberi, S. M., Alsaadi, T., Jain, S., French, J., et al. (2022) · Epilepsia · doi:10.1111/epi.17240 · Cited by 287
Interleukin 6: at the interface of human health and disease
Grebenciucova, E., & VanHaerents, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1255533 · Cited by 281
Metadata
- Authors
- Steriade, C., Britton, J., Dale, R. C., Gadoth, A., Irani, S. R., Linnoila, J., McKeon, A., Shao, X., Venegas, V., & Bien, C. G.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2020-06-16
- Volume
- 61
- Issue
- 7
- Pages
- 1341-1351
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W3034212049
- Cited by
- 265
- References
- 65
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.